Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EF.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XPORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XPNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CQ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CQ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CQ.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.52ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.52NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XMORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBQENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBQNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.6.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used